CapsoVision, Inc Deferred Offering Costs
CapsoVision, Inc (CV) had Deferred Offering Costs of $87.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2026-05-14
- 2026-03-31: Deferred Offering Costs $87.00K.
- 2025-12-31: Deferred Offering Costs $0.00.
- 2025-09-30: Deferred Offering Costs $0.00.
- 2025-06-30: Deferred Offering Costs $1.14M.
| Period end | Deferred Offering Costs |
|---|---|
| 2026-03-31 | $87.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $0.00 10-Q · filed 2026-05-14 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.14M 10-Q · filed 2025-08-14 |
| 2024-12-31 | $225.00K 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |